Tag: venture capital
-
Nerve Stimulation Device Being Tested for Arthritis
A device sending electrical pulses through a main nerve pathway is starting a clinical trial to test the device in people with rheumatoid arthritis, an autoimmune disease affecting joints and surrounding tissue.
-
Immune Disease Precision Therapy Company Starts Up
An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe.
-
Boron Radiation Therapy Company Forms with $40M Funding
A start-up enterprise, spun off from a fusion energy company, plans to develop radiation therapies for solid tumor cancers often considered difficult to treat with conventional methods.
-
Breathalyzer Biopsy Company Gains $15M in New Funds
A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital.
-
Synthetic Bio Company Starts Up, Raises $53 Million
A start-up business that aims to apply principles of computer circuit design to biology and medicine in creating treatments for disease is raising $53 million in its first venture funding round.
-
Gut-Brain Therapies Biotech Raises $66M in New Funds
A 2 year-old biotechnology enterprise discovering new treatments for disease that harness signals between the gut and brain is raising $66 million its second venture financing round.
-
Report – Industry Pain, Addiction Drug Efforts Flagging
A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society.
-
Neuro Therapy Company Spins-Off, Gains $20.8M Funding
A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors.
-
T-Cell Therapy Company Gains $100M in Venture Funds
A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round.
-
RNA Therapies Start-Up Raises $55.3M in Early Funds
A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round.